{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:03:08Z","timestamp":1765040588923,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jns.2015.12.001","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T12:00:30Z","timestamp":1449057630000},"page":"9-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy"],"prefix":"10.1016","volume":"361","author":[{"given":"Yumiko","family":"Nakano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Takao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2015.12.001_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1423-0410.1998.7420074.x","article-title":"IVIG adverse reactions: potential role of cytokines and vasoactive substances","volume":"74","author":"Bagdasarian","year":"1998","journal-title":"Vox Sang."},{"key":"10.1016\/j.jns.2015.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","article-title":"The clinical features of 16 cases of stroke associated with administration of IVIg","volume":"60","author":"Caress","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.12.001_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00415-009-0969-0","article-title":"Case\u2013control study of thromboembolic events associated with IV immunoglobulin","volume":"256","author":"Caress","year":"2009","journal-title":"J. Neurol."},{"issue":"917","key":"10.1016\/j.jns.2015.12.001_bb0020","first-page":"e9","article-title":"Acute cerebellar infarction associated with intravenous gammaglobulin treatment in idiopathic thrombocytopenic purpura","volume":"21","author":"Choi","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2015.12.001_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.44.2.223","article-title":"High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events","volume":"44","author":"Dalakas","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.12.001_bb0030","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.WNL.0000074394.15882.83","article-title":"Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record","volume":"60","author":"Dalakas","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 4","key":"10.1016\/j.jns.2015.12.001_bb0035","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1007\/s10072-003-0082-6","article-title":"Intravenous immunoglobulins in neurological disorders: safety issues","volume":"24","author":"Eibl","year":"2003","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2015.12.001_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4065\/75.1.83","article-title":"Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications","volume":"75","author":"Go","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2015.12.001_bb0045","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.57.9.1699","article-title":"Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders","volume":"57","author":"Grillo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.12.001_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1023\/A:1023239904856","article-title":"Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice","volume":"18","author":"Krause","year":"1998","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jns.2015.12.001_bb0055","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2133.2006.07390.x","article-title":"Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature","volume":"155","author":"Marie","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jns.2015.12.001_bb0060","first-page":"726","article-title":"Primary immunodeficiency diseases: common diseases that exhibit various clinical manifestations","volume":"54","author":"Morio","year":"2013","journal-title":"[Rinsho ketsueki] The Japanese Journal of Clinical Hematology"},{"key":"10.1016\/j.jns.2015.12.001_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.mbc.0000172694.85233.a8","article-title":"Venous and arterial thrombosis following administration of intravenous immunoglobulins","volume":"16","author":"Paran","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jns.2015.12.001_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000056085","article-title":"Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases","volume":"62","author":"Sherer","year":"2001","journal-title":"Pharmacology"},{"key":"10.1016\/j.jns.2015.12.001_bb0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.autrev.2003.11.001","article-title":"5th International Symposium on IVIG: IVIG in the third millenium, 25\u201327 September 2003, Interlaken, Switzerland","volume":"3","author":"Shoenfeld","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jns.2015.12.001_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08916930500059633","article-title":"IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients","volume":"38","author":"Shoenfeld","year":"2005","journal-title":"Autoimmunity"},{"issue":"Suppl. 5","key":"10.1016\/j.jns.2015.12.001_bb0085","doi-asserted-by":"crossref","first-page":"V75","DOI":"10.1007\/s00415-006-5013-z","article-title":"Adverse effects of treatment with intravenous immunoglobulins for neurological diseases","volume":"253","author":"Wittstock","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2015.12.001_bb0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000073059","article-title":"Therapy with intravenous immunoglobulins: complications and side-effects","volume":"50","author":"Wittstock","year":"2003","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2015.12.001_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(86)92511-0","article-title":"Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients","volume":"2","author":"Woodruff","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2015.12.001_bb0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1468-1331.2003.00542.x","article-title":"Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature","volume":"10","author":"Zaidan","year":"2003","journal-title":"Eur. J. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15300678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15300678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:43:59Z","timestamp":1758383039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X15300678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":20,"alternative-id":["S0022510X15300678"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2015.12.001","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}